Nicotine metabolite ratio as an index of cytochrome P450 2A6 metabolic activity
D. Dempsey, P. Tutka, P. Jacob, et al.. (2004). Clinical Pharmacology & Therapeutics. Cited 418 times. https://doi.org/10.1016/j.clpt.2004.02.011Genetic and environmental influences on the ratio of 3′hydroxycotinine to cotinine in plasma and urine
G. Swan, Christina N. Lessov-Schlaggar, A. Bergen, et al.. (2009). Pharmacogenetics and Genomics. Cited 82 times. https://doi.org/10.1097/FPC.0b013e32832a404fEnvironmental and genetic determinants of tobacco use: methodology for a multidisciplinary, longitudinal family-based investigation.
G. Swan, K. Hudmon, L. Jack, et al.. (2003). Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology. Cited 57 times.Pharmacogenetics of Nicotine Metabolism in Twins: Methods and Procedures
G. Swan, N. Benowitz, P. Jacob, et al.. (2004). Twin Research. Cited 45 times. https://doi.org/10.1375/twin.7.5.435Genome-Wide Association of the Laboratory-Based Nicotine Metabolite Ratio in Three Ancestries
J. Baurley, C. Edlund, C. Pardamean, et al.. (2016). Nicotine & Tobacco Research. Cited 39 times. https://doi.org/10.1093/ntr/ntw117Drug Metabolizing Enzyme and Transporter Gene Variation, Nicotine Metabolism, Prospective Abstinence, and Cigarette Consumption
A. Bergen, Martha Michel, D. Nishita, et al.. (2015). PLoS ONE. Cited 24 times. https://doi.org/10.1371/journal.pone.0126113